Ovarian Neoplasms: all 2,757 studies
Page 4 of 28. Open to participants first (735), then studies with results posted, then the rest; newest registration first within each.
- Dysregulation of Whole-body Metabolism in Ovarian Cancer: A Longitudinal StudyRecruitingNCT06800105
- Study of XNW28012 in Subjects With Advanced Solid Tumors Who Failed Standard TreatmentsRecruitingNCT06799637Phase 1/2
- First-in-Human Study of ATX-295, an Oral Inhibitor of KIF18A, as Monotherapy and in Combination With Anticancer Therapy in Patients With Advanced or Metastatic Solid Tumors, Including Ovarian CancerRecruitingNCT06799065Phase 1/2
- Pegylated Liposomal Doxorubicin Plus Adebrelimab With or Without Mirabegron in Relapsed Ovarian CancerRecruitingNCT06791460Phase 2/3
- Investigation of Ubamatamab Combination Therapy in Adult Participants With Platinum-Resistant Ovarian CancerRecruitingNCT06787612Phase 2
- A Study to Explore Personalized Treatment for Patients With Recurrent Gynecological Malignancies Based on MTBRecruitingNCT06781151
- A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H MutationRecruitingNCT06778863Phase 1
- Reproductive Health Outcomes Among Young Women With Ovarian Neoplasms Following SurgeryNot yet recruitingNCT06777147
- Impact of Different BRCA1/2 Gene Variants on Response to Therapy and Prognosis of Ovarian CancerRecruitingNCT06775470
- A Phase 1 Study of LNCB74 in Advanced Solid TumorsRecruitingNCT06774963Phase 1
- HS-10502 Combination Treatment in Patients With Advanced Solid TumorsRecruitingNCT06769425Phase 1
- A Phase II Clinical Study to Evaluate the Efficacy and Safety of HLX43 (Anti-PD-L1 ADC) in Patients With Advanced Gynecological Malignant TumorsRecruitingNCT06769152Phase 2
- A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)RecruitingNCT06760819Phase 2
- Evaluating an Evidence-Based Family History Screening Program Adapted to Increase Reach and Uptake of Screening for BRCA-Associated Cancers in Rural Public Health ClinicsRecruitingNCT06760507Not applicable
- Expanded Access Program (EAP) Designed to Provide Access to Botensilimab and Balstilimab Before Regulatory ApprovalAvailableNCT06751524
- JSKN003 in Platinum-Resistant, Relapsed Epithelial Ovarian CancerNot yet recruitingNCT06751485Phase 3
- A Study of DM002 in Patients With Advanced Solid TumorsRecruitingNCT06751329Phase 1/2
- EPITOME-1015-I: a Study to Investigate the Safety and Tolerability of MDG1015 in Patients with Epithelial Ovarian Cancer, Gastroesophageal Adenocarcinoma, Round Cell Liposarcoma And/or Synovial SarcomaNot yet recruitingNCT06748872Phase 1
- A Study of BL0175 Injection in Postmenopausal Female Adults With HR-positive, Locally Advanced or Metastatic CancerRecruitingNCT06738966Phase 1
- Fluzoparib With or Without Bevacizumab for Neoadjuvant Therapy in Advanced Ovarian CancerRecruitingNCT06735326Phase 2
- Utidelone Capsule Monotherapy for Patients with Advanced Solid TumorsNot yet recruitingNCT06730581Phase 2
- Pharmacokinetic Study of Tranexamic AcidRecruitingNCT06728670Not applicable
- The CCANED-CIPHER Study: Early Cancer Detection and Treatment Response Monitoring Using AI-Based Platelet and Immune Cell Transcriptomic ProfilingRecruitingNCT06717295
- Lead-212 PSV359 Therapy for Patients With Solid TumorsRecruitingNCT06710756Phase 1/2
- REVITALIZE: RCT to Reduce Fatigue in Adults With Ovarian Cancer on PARP InhibitorsRecruitingNCT06710548Not applicable
- A Prospective Multicenter Diagnostic Biomarker Study to Discriminate Borderline From Stage I Invasive Ovarian CancerRecruitingNCT06709872
- Establishment and Clinical Application of AI-based Multimodal Diagnosis System for Ovarian TumorsNot yet recruitingNCT06703112Not applicable
- A Phase 2 Study of Zanidatamab in Patients With HER2-expressing TumorsRecruitingNCT06695845Phase 2
- Masses in Young Patients - International Ovarian Tumour Analysis (MY-IOTA)RecruitingNCT06693596
- Ultrasound-guided Tru-cut Biopsy in Patients with Suspected Ovarian Cancer: Adequacy, Accuracy, Safety and Patient Assessment.RecruitingNCT06689605
- Combination Therapy of AK112 With Chemotherapy and/or Olaparib in Platinum-sensitive Ovarian CancerRecruitingNCT06686030Phase 2
- Belzutifan in Recurrent Clear Cell Carcinoma of Gynecologic OriginRecruitingNCT06677190Phase 2
- The Application of Sentinel Lymph Node Mapping Technique in the Surgery of Early Epithelial Ovarian CancerNot yet recruitingNCT06673511Not applicable
- Study of SYN818 for the Treatment of Advanced or Metastatic Solid TumorsRecruitingNCT06666270Phase 1
- The SENTRY Study: Testing Whether Changes in Platelet RNA Enhance the Early Diagnosis of Ovarian CancerRecruitingNCT06665945
- Exploratory Study on the Safety and Efficacy of Disitamab Vedotin in Combination with Anlotinib Hydrochloride for the Treatment of HER-2-expressing Recurrent Platinum-resistant Ovarian Cancer.RecruitingNCT06660511Early Phase 1
- Phase 1 Dose Escalation and Expansion to Evaluate AROG4-01 in Patients With Advanced Solid TumorsNot yet recruitingNCT06652529Phase 1
- NEoadjuvant Olaparib Combination OvArian Cancer Targeted StudyNot yet recruitingNCT06650709Phase 2
- Clinical Trial of Autologous B7-H3 CAR T Cells in Reoccurent Platinum-resistant Ovarian TumorsRecruitingNCT06646627Phase 1
- Ultrasensitive SERS Platform With Highly Efficient Enrichment of Analyte for Screening and Diagnosis of Epithelial Ovarian CancerRecruitingNCT06640348
- Exploratory Study on the Correlation Between HRD Score and PARPi Efficacy Based on Chinese Ovarian Cancer PatientsRecruitingNCT06622798
- BMX-001 + Paclitaxel in Adult Patients With Advanced, Recurrent, Metastatic Ovarian or Endometrial CancerNot yet recruitingNCT06620029Phase 1/2
- Trial of THEO-260 in Ovarian Cancer PatientsRecruitingNCT06618235Phase 1/2
- Study of Senaparib in Combination With Temozolomide in ARID1A Mutation Associated Ovarian CancerRecruitingNCT06617923Phase 2
- The Role of CircDENND4C in Epithelial Ovarian CancerNot yet recruitingNCT06617585
- Niraparib Maintenance Treatment in Patients With Newly Diagnosed Advanced Platinum- Sensitive, OC. The First Poland RWE Study.RecruitingNCT06614790
- OveRcoming immunosupprEssion aNd rebAlancing the Immune reSponSe in ovAriaN CancEr StudyRecruitingNCT06611072Not applicable
- Surgery for Relapsed Ovarian Cancer in PrecisionNot yet recruitingNCT06602063Phase 1/2
- Adebrelimab Combined with Non-platinum Chemotherapy and Fuzuloparib in Recurrent Platinum-resistant Ovarian CancerNot yet recruitingNCT06600841Phase 2
- A Study of Niraparib in Combination With Abemaciclib for Late Line Treatment of Ovarian Cancer (NICHOL TRIAL)RecruitingNCT06594679Phase 1/2
- Detection of Homologous Recombination Pathway Gene Mutations in Circulating Tumour DNA From BRCA-mutated Ovarian Cancer Patients Receiving First-line PARP Inhibitor Maintenance TherapyRecruitingNCT06588322Not applicable
- A Study With NKT3964 for Adults With Advanced/Metastatic Solid TumorsRecruitingNCT06586957Phase 1
- Quest to Analyze One Thousand Humans MeditatingEnrolling by invitationNCT06583395
- Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple MyelomaRecruitingNCT06582017Phase 1
- Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian CancerRecruitingNCT06580314Phase 3
- Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot TrialRecruitingNCT06580002Phase 2
- Neoadjuvant RC48 Plus Carboplatin for HER2-expressing Advanced Ovarian CancerNot yet recruitingNCT06574763Phase 2
- Study on the Relative Dose Intensity of PARP Inhibitors in Real-life on a Population of Patients Over 70 Years With Advanced Ovarian CancerRecruitingNCT06572735
- A Diagnostic Test to Evaluate Cancer Risk Before Surgery in Women with an Ovarian MassRecruitingNCT06566716
- A Cohort Study of Hereditary Ovarian Cancer Risk Prediction Models and Pathogenesis ExplorationRecruitingNCT06564428
- SY001 Targets Mesothelin in a Single-arm, Dose-increasing Setting in Subjects With Advanced Solid TumorsRecruitingNCT06562647Not applicable
- An Exploratory, Multi-cohort Phase II Study of Combination Therapy With AK104 and AK112 for Recurrent Ovarian CancerRecruitingNCT06560112Phase 2
- Exosome-based OCS Scores for Predicting Ovarian Cancer RecurrenceNot yet recruitingNCT06558019
- The Efficacy and Safety of FRD001 in Ultrasound Contrast Imaging for Malignant Ovarian Masses in WomenRecruitingNCT06556342Not applicable
- High Definition Profiling of Ovarian Cancer AscitesNot yet recruitingNCT06553742
- Fluzoparib Combined With Dalpiciclib for Platinum Resistant Recurrent Ovarian CancerNot yet recruitingNCT06552858Phase 2
- Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid TumorsRecruitingNCT06545942Phase 1
- Comprehensive Yoga Therapy Based Lifestyle Prehabilitation Program for Women With Ovarian CancerRecruitingNCT06545604Not applicable
- Secondary Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for PARP Inhibitors Resistance PatientsNot yet recruitingNCT06544460Phase 2
- Pilot Randomized Controlled Trial of a Collaborative Agenda-setting Intervention (CASI) for Patients With Ovarian CancerRecruitingNCT06543537Not applicable
- Efficacy and Safety of AK104 (PD-1/CTLA-4 Bispecial Antibody) Combined With Chemotherapy for Neoadjuvant Treatment of Advanced Ovarian CancerNot yet recruitingNCT06542549Phase 3
- Fluzoparib Neoadjuvant Therapy for Ovarian CancerRecruitingNCT06541314Phase 2
- A New Fast DWI-based MR Protocol for Surveillance in Patients With a High Risk of Ovarian Cancer Recurrence During PARP-inhibitors Maintenance to Enhance Secondary Cytoreduction ResultsNot yet recruitingNCT06541171
- RC48 in Combination With AK104 and Bevacizumab in OCCCRecruitingNCT06540729Phase 2
- Fluzoparib in Combination With Apatinib Mesylate for Maintenance Therapy in Stage III-IV Ovarian CancerNot yet recruitingNCT06539091Phase 3
- Intraperitoneal Chemotherapy in Recurrent Ovarian CancerNot yet recruitingNCT06535334
- Satisfactory Debulking Prediction Model for Advanced Ovarian Cancer Based on PET-CT Image DataRecruitingNCT06533709
- A Phase 1 Trial of ERX-315 in Participants With Advanced Solid TumorsRecruitingNCT06533332Phase 1
- A Study of XS-02 Capsules in Patients With Advanced Solid TumorsNot yet recruitingNCT06531486Phase 1/2
- Research and Application of Ultrasonic Intelligent Diagnosis System for Ovarian MassNot yet recruitingNCT06528236
- Gonadal Dysgenesis Tissue Cryopreservation for Fertility PreservationRecruitingNCT06518746Not applicable
- A Study of QL1706 (an Anti-PD-1/CTLA-4 Combined Antibody) Combined With Albumin-bound Paclitaxel and Bevacizumab in the Treatment of Platinum-resistant Recurrent Ovarian CancerNot yet recruitingNCT06509971Phase 2
- A Phase I Clinical Study of Intratumoral Injection Oncolytic Vaccinia Virus GC001 in Patient With Advanced Solid TumorsRecruitingNCT06508307Phase 1
- A Study of Radspherin® in Patients With Primary Advanced Epithelial Cancer, With Peritoneal Metastasis That Are Homologous Recombination Proficient Scheduled to Undergo Neoadjuvant Chemotherapy and Interval Debulking SurgeryRecruitingNCT06504147Phase 2
- 18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer DetectionRecruitingNCT06503146Phase 2
- Cryocompression With or Without Cilostazol for the Prevention of Paclitaxel-induced Neuropathy in Patients With Gynecological CancersRecruitingNCT06492070Phase 2
- MUC1-Activated T Cells for the Treatment of Relapsed and Resistant Ovarian CancerRecruitingNCT06483048Phase 1
- Utility of Adjusting Chemotherapy Dose & Dosing Schedule With the SALVage Weekly Dose-dense Regimen in Patients With Poor Prognostic OVARian Cancers Based on the Tumor Unfavorable Primary Chemosensitivity and Incomplete Debulking SurgeryRecruitingNCT06476184Phase 3
- Ultrasound RF Data for Discriminating Between Benign and Malignant Ovarian MassesRecruitingNCT06473766Not applicable
- A Study to Learn if 27T51, a Mucin-16 (MUC16) Protein Targeting Immune Cell Therapy, Administered Alone or in Combination is Safe and How Well it Works for Adult Participants With Recurrent or Treatment Resistant Ovarian CancersRecruitingNCT06469281Phase 1
- A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid TumorsRecruitingNCT06465069Phase 1
- Feasibility of CALM in Patients With Ovarian CancerRecruitingNCT06459271Not applicable
- Cancer Loyalty Card Study 2 (CLOCS-2)RecruitingNCT06447064
- Adebrelimab Plus Chemotherapy, Bevacizumab and Fluzoparib in Platinum-Sensitive Relapsed Ovarian CancerNot yet recruitingNCT06446206Phase 2
- Early Detection of Relapse in Ovarian Cancer Using Capillary Home-sampling and a Protein Biomarker TestRecruitingNCT06445621
- Surufatinib Combined With Carboplatin/Paclitaxel and Surufatinib Combined With Olaparib as First-line and Maintenance Therapy for Newly Diagnosed High-risk Ovarian CancerRecruitingNCT06437353Phase 2
- Study of Psilocybin Assisted Psychotherapy to Address Fear of RecurrenceRecruitingNCT06430541Phase 1
- Access to Genetic Testing in Underserved Patients With CancerRecruitingNCT06422455Not applicable
- RC48 Treatment for Platinum Sensitive Recurrent Ovarian Cancer With HER2 ExpressionRecruitingNCT06420973Phase 2
- Study Evaluating Safety, Tolerability, and Metabolism of NiraparibRecruitingNCT06412120Phase 4